Investor directory
4BIO Capital
4BIO Capital invests in early-stage life sciences companies focused on advanced therapies.
What they invest in
Sectors
Geographies
Greater London
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- London, United Kingdom
- Founded
- 2014
Portfolio
Arvinas (NAS: ARVN)Cellectis (PAR: ALCLS)ADC Therapeutics (NYS: ADCT)Orchard TherapeuticsDicerna PharmaceuticalsRay TherapeuticsAutolus (NAS: AUTL)Carisma Therapeutics (OTCM: CARM)Code BioEntactbioAscend (Drug Discovery)ActitheraSparingVisionMarch BiosciencesHornet TherapeuticsRedpin TherapeuticsViaNautisCytospireTrogenixArarisLUCA ScienceNV TherapeuticsAtara Biotherapeutics (NAS: ATRA)
Does 4BIO Capital fit your round?
Oka scores this fund against your actual raise — stage, sector, cheque size and traction — and shows you who can introduce you.
Check your matchAre you 4BIO Capital? Tell us what to correct and we will update it — or ask us to remove the entry.